Knowledge Center
Patent / Jan 24, 2019
Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease
Source:
WO 2019016512 20190124
The present invention relates to an amorphous form of vilanterol trifenatate, processes for its prepn. and its use in pharmaceutical formulations for the treatment of respiratory diseases, particularly for the treatment of asthma and chronic obstructive pulmonary disease.Ìý In particular, the invention relates to an amorphous form of vilanterol trifenatate, characterized by the x-ray powder diffraction (XRPD) pattern, obtained using copper K-α1 radiation.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Apr 20, 2017
Method of production of inhalable composite particles using a three-fluid nozzle
Read more
Scientific Article
/ Dec 07, 2016
Impact of Spray Drying on Superoxide Dismutase Activity in Composite Systems with Optimal Aerodynamic Performance for Dry Powder Inhalers
Read more
Scientific Article
/ Dec 07, 2016
Optimization of Supercritical CO2 Assisted Spray Drying for the Production of Inhalable Composite Particles
Read more
Scientific Article